Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
2.380
-0.040 (-1.65%)
May 22, 2026, 4:00 PM EDT - Market closed
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $56.94 million as of May 22, 2026. Its market cap has decreased by -70.55% in one year.
Market Cap
56.94M
Enterprise Value
48.81M
1-Year Change
-70.55%
Ranking
Category
Stock Price
$2.38
Market Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has decreased from $152.13M to $56.94M, a decrease of -62.57%. That is a compound annual growth rate of -42.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 56.94M | -59.97% |
| Dec 31, 2025 | 142.25M | -8.50% |
| Dec 31, 2024 | 155.47M | 2.20% |
| Aug 13, 2024 | 152.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immutep | 63.02M |
| Cingulate | 62.93M |
| Entera Bio | 62.52M |
| Filana Therapeutics | 62.32M |
| ImageneBio | 62.26M |
| Dogwood Therapeutics | 60.46M |
| BeyondSpring | 59.21M |
| Impact BioMedical | 57.35M |